Emergence Therapeutics
Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need.
Emergence Therapeutics has raised €87M across 1 funding round from 1 investor, most recently a round in Dec 2021. Based in Duisburg, Germany; active in Healthtech. Data as of 28 Oct 2026.
Duisburg, Germanyemergencetx.com ↗
Total raised
€87M
€87,000,000
Funding rounds
1
Investors
1
distinct backers
Active since
2021-12
latest 2021-12
Funding by year
EUR raised per yearEmergence Therapeutics — funding by year — interactive chart.
Data table
| Emergence Therapeutics — funding by year | |
|---|---|
| 2021 | €87M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-12-07 | Other | €87M | Pontifax Funds | View deal → |
Investors
1Related news
Similar companies
same sector or country- Delivery Hero€7.1BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Helsing€2.9BGermany · AI
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
Global coverage: FundingData